SUMMARY
# Microglial Contributions to Huntington's Disease Pathogenesis
## Background and Rationale
Microglial dysfunction represents a critical but understudied component of Huntington's disease pathogenesis, with these brain-resident immune cells exhibiting complex phenotypic transitions that can either exacerbate or ameliorate neurodegeneration depending on disease stage and environmental context. Unlike the relatively well-characterized role of mutant huntingtin in neurons, microglial contributions
METHODOLOGY NOTES
**Phase 1: Patient Recruitment and Sample Collection (Months 1-6)**
• Recruit 120 participants: 40 HD patients (early stage, CAG 40-50 repeats), 40 HD patients (advanced stage, CAG >50 repeats), 40 age-matched controls
• Collect CSF samples via lumbar puncture for cytokine analysis and microglial markers
• Obtain blood samples for peripheral immune profiling and genetic confirmation
• Perform comprehensive neurological assessment using UHDRS total motor score
• Conduct MRI imaging with DTI and structural sequences
**Phase 2: Post-mortem Tissue Analysis (Months 3-12)**
• Obtain fresh-frozen brain tissue from 30 HD cases (15 early, 15 late stage) and 15 controls
• Perform immunohistochemical staining for microglial markers: Iba1, CD68, TMEM119, P2RY12
• Quantify microglial morphology using 3D reconstructions in striatum, cortex, and hippocampus
• Measure co-localization of activated microglia with huntingtin aggregates using proximity ligation assay
• Analyze tissue cytokine levels via